134 related articles for article (PubMed ID: 7548603)
1. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Brook I
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
[No Abstract] [Full Text] [Related]
2. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Brook I
J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
Brook I
J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175
[TBL] [Abstract][Full Text] [Related]
4. Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Brook I
Antimicrob Agents Chemother; 1993 Jul; 37(7):1531-5. PubMed ID: 8363386
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
Brook I
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S425-6. PubMed ID: 8324161
[No Abstract] [Full Text] [Related]
6. In-vitro susceptibility and in-vivo efficacy of antimicrobials in the treatment of intraabdominal sepsis in mice.
Brook I; Gillmore JD
J Antimicrob Chemother; 1993 Mar; 31(3):393-401. PubMed ID: 8486573
[TBL] [Abstract][Full Text] [Related]
7. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
Hau T; Jacobs DE; Hawkins NL
Arch Surg; 1986 Feb; 121(2):163-8. PubMed ID: 3511886
[TBL] [Abstract][Full Text] [Related]
9. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
Falagas ME; Barefoot L; Griffith J; Ruthazar R; Snydman DR
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):913-21. PubMed ID: 9031873
[TBL] [Abstract][Full Text] [Related]
10. The interaction of glucan and cefoxitin in prevention of murine abscess.
Hull CC; Stellato TA; Rhodes RS; Galloway P; Hawkins NL
Curr Surg; 1986; 43(5):416-8. PubMed ID: 3533446
[No Abstract] [Full Text] [Related]
11. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
Gisby J; Beale AS
Antimicrob Agents Chemother; 1988 Dec; 32(12):1830-3. PubMed ID: 3072924
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
Beale AS; Gisby J
Infection; 1991; 19(2):101-5. PubMed ID: 2050417
[TBL] [Abstract][Full Text] [Related]
15. Comparative chemotherapeutic activity of temafloxacin, cefoxitin, clindamycin, imipenem and ampicillin/sulbactam against Bacteroides fragilis in a mouse subcutaneous abscess model.
Alder J; Clement JJ
J Antimicrob Chemother; 1993 Feb; 31(2):303-11. PubMed ID: 8463174
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.
Rice LB; Carias LL; Shlaes DM
Antimicrob Agents Chemother; 1993 Mar; 37(3):610-2. PubMed ID: 8460928
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial.
Bracero LA
Gynecol Obstet Invest; 1997; 44(1):21-5. PubMed ID: 9251949
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
[TBL] [Abstract][Full Text] [Related]
19. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.
Goldstein EJ; Citron DM; Cherubin CE
Antimicrob Agents Chemother; 1991 Sep; 35(9):1868-74. PubMed ID: 1952860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]